Abstract:Mitochondria are the major source of energy for the normal functioning of brain cells. Increasing evidence suggests mitochondrial oxidative damage might be one of early events in Alzheimer's disease (AD) progression. Estrogen has been shown to suppress mitochondrial oxidative stress, regulate energy metabolism, and regulate the expression of mitochondria-involved anti-apoptotic proteins like bcl-2 family and bcl-xL, which suggests that brain mitochondria may be major targets of estrogen action in the central nervous system. Studies also demonstrated that many of these protective effects can be blocked by an estrogen receptor (ER) antagonist, ICI-182780, suggesting an ER-mediated mode of estrogen action. Even more interestingly, recent reports have confirmed the localization of ERb in the mitochondria and suggested that estrogen can directly affect mitochondrial function through mitochondrial ERb (mtERb). To address whether female AD brains exhibit mitochondrial impairment and whether it is correlated with estrogen receptors, we conducted mitochondrial functional analyses in female AD patients and age-matched non-demented (ND) individuals. Using frontal cortex samples from the brains of age-matched AD and non-ND women, we examined mitochondrial cytochrome C oxidase (COX) activity, and reactive oxygen species (ROS)-induced intracellular protein oxidation as protein carbonylation along with receptor-b (ERb) sub cellular distribution and protein expression. In order to investigate whether lacking of ERb causes mitochondrial dysfunction, mice with ERb gene knockout were used as an animal model. First, we found that the frontal cortices of female AD patients exhibited significantly reduced ERb expression, including in mitochondrial fraction, reduced mitochondrial COX activity, and increased protein carbonylation compared to the samples from ND. A significant linkage between the mitochondrial ERb expression and mitochondrial COX activity were observed in the female human brain, suggesting an involvement of ERb in mitochondrial function in the brain. Second, we noticed that mitochondria from the brains of ERb-knockout mice exhibited increased ROS generation and reduced mitochondrial membrane potential (MMP) under b-amyloid (Ab1-42 or Ab25-35) insult compared to brain mitochondria from wild-type control mice. These results suggest that ERb depletion can impair mitochondrial function in mice and may significantly contribute to the mitochondrial dysfunction involved in AD pathogenesis in women. Although further investigation is needed, our novel detection of ERb expression in neuronal mitochondria in the female human brain along with the direct correlation of mtERb expression with COX activity and the significant decrease of mtERb in the AD brain suggest a possible connection between ERb and mitochondrial dysfunction in AD. This hypothesis is supported by our experiments involving transgenic ERb knockout mice, which showed that ERb deficiency leads to mitochondrial dysfunction in the brain by decreasing MMP and by increasing mitochondrial vulnerability to Ab-induced ROS generation. Together, the results of this study indicate that ERb deficiency may play an important role in AD pathogenesis in females by contributing to mitochondrial dysfunction.

ERβ mediates sex-specific protection in the App-NL-G-F mouse model of Alzheimer's disease

ERβ mediates sex-specific protection in the mouse model of Alzheimer′s disease

Estrogen Receptor Β Exerts Neuroprotective Effects by Fine-Tuning Mitochondrial Homeostasis Through NRF1/PGC-1α

Sex Differences in Hippocampal Β-Amyloid Accumulation in the Triple-Transgenic Mouse Model of Alzheimer’s Disease and the Potential Role of Local Estrogens

Brain Endogenous Estrogen Levels Determine Responses to Estrogen Replacement Therapy via Regulation of BACE1 and NEP in Female Alzheimer’s Transgenic Mice

The novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer's mouse model

P3‐182: Genetic Knockout of Estrogen Receptor‐ïβ¢ Contributes to Alzheimer's Disease Pathogenesis by Impairing Mitochondrial Function in Females

Neuroprotective Effect of Estrogen: Role of Nonsynaptic Nr2b-Containing Nmda Receptors

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.

Estrogen Receptors and Type 1 Metabotropic Glutamate Receptors Are Interdependent in Protecting Cortical Neurons against β-Amyloid Toxicity

Estrogen Stimulates Degradation of Beta-Amyloid Peptide by Up-Regulating Neprilysin

Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases

Sex‐specific impact of brain estrogen deficiency on astrocyte reactivity, neurodegeneration, and memory loss in aromatase knockout mouse models

Neuroprotective Effects of Estrogen on Beta‐Amyloid Induced Neurotoxicity in Murine Hypothalamic Cells

Estrogen receptor α: a critical role in successful female cognitive aging

Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function

Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy

Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates Β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive Impairment

Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice

Linking alterations in estrogen receptor expression to memory deficits and depressive behavior in an ovariectomy mouse model

The role of estrogen in Alzheimer's disease pathogenesis and therapeutic potential in women